Read More Pharma Industry News Can Moleculin’s MIRACLE trial redefine AML treatment? Company to showcase study at leukemia event Find out how Moleculin’s MIRACLE phase 3 trial could reshape AML treatment as the company presents its latest progress at the Madrid leukemia meeting. bySoujanya RaviOctober 31, 2025